A cleavable signal peptide enhances cell surface delivery and heterodimerization of Cerulean-tagged angiotensin II AT1 and bradykinin B2 receptor

Biochemical and Biophysical Research Communications

Volumn 409, Issue 3, 2011, Pages 544-549

  Quitterer, Ursula ^a   Pohl, Armin ^a   Langer, Andreas ^a   Koller, Samuel ^a   AbdAlla, Said ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

AGTR1; BDKRB2; Cerulean; Fluorescence resonance energy transfer (FRET); G protein coupled receptor; Receptor heterodimer

Indexed keywords

ANGIOTENSIN 2 AT1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; BRADYKININ B2 RECEPTOR; CERULEAN; DYE; ENHANCED YELLOW FLUORESCENT PROTEIN; G PROTEIN COUPLED RECEPTOR KINASE; GREEN FLUORESCENT PROTEIN; PROTEIN SERINE THREONINE KINASE INHIBITOR; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIMERIZATION; EMBRYO; FLUORESCENCE RESONANCE ENERGY TRANSFER; HETERODIMERIZATION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VITRO STUDY; INHIBITION KINETICS; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; SENSITIVITY ANALYSIS;

CELL MEMBRANE; FLUORESCENCE RESONANCE ENERGY TRANSFER; G-PROTEIN-COUPLED RECEPTOR KINASES; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; PROTEIN MULTIMERIZATION; PROTEIN SORTING SIGNALS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, BRADYKININ B2;

EID: 80955177132     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.05.041     Document Type: Article

References (21)

1. Ljungman S., Aurell M., Hartford M., et al. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure. Hypertension 1983, 5:368-374.
2. Widgren B.R., Herlitz H., Aurell M., et al. Increased systemic and renal vascular sensitivity to angiotensin II in normotensive men with positive family histories of hypertension. Am. J. Hypertens. 1992, 5:167-174.
3. Fior D.R., Hedlund P.B., Fuxe K. Autoradiographic evidence for a bradykinin/angiotensin II receptor-receptor interaction in the rat brain. Neurosci. Lett. 1993, 163:58-62.
4. AbdAlla S., Lother H., Quitterer U. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor activation. Nature 2000, 407:94-98.
5. Zeng C., Luo Y., Asico L.D., et al. Perturbation of D1 dopamine and AT1 receptor interaction in spotaneously hypertensive rats. Hypertension 2003, 42:787-792.
6. Barki-Harrington L., Luttrell L.M., Rockman H.A. Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interactions in vivo. Circulation 2003, 108:1611-1618.
7. AbdAlla S., Lother H., Langer A., et al. Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis. Cell 2004, 119:343-354.
8. AbdAlla S., Lother H., el Massiery A., et al. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat. Med. 2001, 7:1003-1009.
9. AbdAlla S., Abdel-Baset A., Lother H., et al. Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension. J. Mol. Neurosci. 2005, 26:185-192.
10. Abd Alla J., Reeck K., Langer A., et al. Calreticulin enhances B2 bradykinin receptor maturation and heterodimerization. Biochem. Biophys. Res. Commun. 2009, 387:186-190.
11. Abd Alla J., Pohl A., Reeck K., et al. Establishment of an in vivo model facilitates B2 receptor protein maturation and heterodimerization. Integr. Biol. 2010, 2:209-217.
12. Gandia J., Lluis C., Ferre S., et al. Light resonance energy transfer-based methods in the study of G protein-coupled receptor oligomerization. Bioessays 2008, 30:82-89.
13. Karpova T.S., Baumann C.T., He L., et al. Fluorescence resonance energy transfer from cyan to yellow fluorescent protein detected by acceptor photobleaching using confocal microscopy and a single laser. J. Microsc. 2003, 209:56-70.
14. Rizzo M.A., Springer G.H., Granada B., et al. An improved cyan fluorescent protein variant useful for FRET. Nat. Biotechnol. 2004, 22:445-449.
15. Guan X.M., Kobilka T.S., Kobilka B.K. Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide. J. Biol. Chem. 1992, 267:21995-21998.
16. Winstel R., Ihlenfeldt H.G., Jung G., et al. Peptide inhibitors of G protein-coupled receptor kinases. Biochem. Pharmacol. 2005, 70:1001-1008.
17. AbdAlla S., Lother H., el Missiry A., et al. Dominant negative AT2 receptor oligomers induce G-protein arrest and symptoms of neurodegeneration. J. Biol. Chem. 2009, 284:6566-6574.
18. Oppermann M., Freedman N.J., Alexander R.W., et al. Phosphorylation of the type 1A angiotensin II receptor by G protein-coupled receptor kinases and protein kinase C. J. Biol. Chem. 1996, 271:13266-13272.
19. Hillion J., Canals M., Torvinen M., et al. Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J. Biol. Chem. 2002, 277:18091-18097.
20. AbdAlla S., Zaki E., Lother H., et al. Involvement of the amino terminus of the B2 receptor in agonist-induced receptor dimerization. J. Biol. Chem. 1999, 274:26079-26084.
21. Jordan B.A., Devi L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 1999, 399:697-700.